PubAg

Main content area

Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes

Author:
Labonté, Marie-Ève, Couture, Patrick, Tremblay, André J, Hogue, Jean-Charles, Lemelin, Valéry, Lamarche, Benoît
Source:
Nutrition journal 2013 v.12 no.1 pp. 678
ISSN:
1475-2891
Subject:
anti-inflammatory activity, biopsy, corn oil, docosahexaenoic acid, duodenum, eicosapentaenoic acid, fish oils, gene expression, genes, humans, inflammation, interleukins, long chain polyunsaturated fatty acids, men, messenger RNA, noninsulin-dependent diabetes mellitus, patients, placebos, polymerase chain reaction, transcription factors, tumor necrosis factors
Abstract:
The extent to which long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) from fish oil such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exert their anti-inflammatory effects by down-regulating intestinal inflammation in humans is unknown. We investigated the impact of LCn-3PUFA supplementation on inflammatory gene expression in the duodenum of obese patients with type 2 diabetes. This placebo-controlled randomized crossover study included 12 men with type 2 diabetes. After a 4-week run-in period, patients received in a random sequence 5 g/d of fish oil (providing 3 g of EPA + DHA) and a placebo (corn and soybean oil) for 8 weeks each. The two treatment phases were separated by a 12-week washout period. Gene expression was assessed by real-time polymerase chain reaction in duodenal biopsy samples obtained in the fasted state at the end of each treatment phase. Intestinal mRNA expression levels of interleukin (IL)-6 and tumor-necrosis factor (TNF)-α were hardly detectable after either treatment (<100 copies/105 copies of the reference gene ATP5o). Intestinal mRNA expression of IL-18 and of the transcription factor signal transducer and activator of transcription 3 (STAT3) was higher (>5000 copies/105 copies ATP5o) but still relatively low. EPA + DHA supplementation had no impact on any of these levels (all P ≥ 0.73). These data suggest that duodenal cells gene expression of pro-inflammatory cytokines is low in patients with type 2 diabetes and not affected by EPA + DHA supplementation. Further studies are warranted to determine if inflammatory gene expression in other tissues surrounding the intestine is modulated by EPA + DHA supplementation. ClinicalTrials.gov ID: NCT01449773.
Agid:
601797